Research statistics

Hexarelin (Examorelin) research: publications and trials

What has been published on Hexarelin (Examorelin): PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Hexarelin (Examorelin) works or is safe. For what it is and what the studies found, see the Hexarelin (Examorelin) profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

289

Since 1994

Publications in 2026 so far

4

Through November 15, 2026

Human clinical research

35.2%

100 of 284 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

25

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

53.9%

118 animal · 34 in vitro · 1 computational

Records that only mention it

25

Not counted above

Status in the library: Research only. Groups: Growth hormone axis. 5 publications are not yet classified by study type.

Publications by year

Hexarelin (Examorelin) publications by year and evidence

1994, Human clinical research: 4 of 61994, Preclinical (animal, in vitro, computational): 2 of 61995, Human clinical research: 13 of 161995, Preclinical (animal, in vitro, computational): 3 of 161996, Human clinical research: 9 of 121996, Preclinical (animal, in vitro, computational): 3 of 121997, Human clinical research: 18 of 281997, Preclinical (animal, in vitro, computational): 6 of 281997, Reviews and meta-analyses: 4 of 281998, Human clinical research: 15 of 311998, Preclinical (animal, in vitro, computational): 11 of 311998, Reviews and meta-analyses: 5 of 311999, Human clinical research: 15 of 291999, Preclinical (animal, in vitro, computational): 8 of 291999, Reviews and meta-analyses: 2 of 291999, Other and not yet classified: 4 of 292000, Human clinical research: 8 of 212000, Preclinical (animal, in vitro, computational): 12 of 212000, Reviews and meta-analyses: 1 of 212001, Human clinical research: 5 of 202001, Preclinical (animal, in vitro, computational): 11 of 202001, Reviews and meta-analyses: 4 of 202002, Human clinical research: 5 of 172002, Preclinical (animal, in vitro, computational): 10 of 172002, Reviews and meta-analyses: 1 of 172002, Other and not yet classified: 1 of 172003, Human clinical research: 2 of 102003, Preclinical (animal, in vitro, computational): 7 of 102003, Reviews and meta-analyses: 1 of 102004, Human clinical research: 3 of 102004, Preclinical (animal, in vitro, computational): 5 of 102004, Reviews and meta-analyses: 2 of 102005, Preclinical (animal, in vitro, computational): 3 of 62005, Reviews and meta-analyses: 3 of 62006, Human clinical research: 1 of 62006, Preclinical (animal, in vitro, computational): 5 of 62007, Human clinical research: 1 of 32007, Preclinical (animal, in vitro, computational): 2 of 32008, Preclinical (animal, in vitro, computational): 4 of 62008, Reviews and meta-analyses: 1 of 62008, Other and not yet classified: 1 of 62009, Preclinical (animal, in vitro, computational): 5 of 52010, Preclinical (animal, in vitro, computational): 4 of 42011, Preclinical (animal, in vitro, computational): 3 of 42011, Reviews and meta-analyses: 1 of 42012, Preclinical (animal, in vitro, computational): 7 of 72013, Preclinical (animal, in vitro, computational): 5 of 52014, Preclinical (animal, in vitro, computational): 4 of 52014, Reviews and meta-analyses: 1 of 52015, Human clinical research: 1 of 42015, Preclinical (animal, in vitro, computational): 2 of 42015, Reviews and meta-analyses: 1 of 42016, Preclinical (animal, in vitro, computational): 4 of 42017, Preclinical (animal, in vitro, computational): 4 of 42018, Preclinical (animal, in vitro, computational): 4 of 52018, Reviews and meta-analyses: 1 of 52019, Preclinical (animal, in vitro, computational): 3 of 32020, Preclinical (animal, in vitro, computational): 3 of 32021, Preclinical (animal, in vitro, computational): 4 of 52021, Other and not yet classified: 1 of 52022, Preclinical (animal, in vitro, computational): 1 of 12023, Preclinical (animal, in vitro, computational): 3 of 32024, Preclinical (animal, in vitro, computational): 1 of 12025, Preclinical (animal, in vitro, computational): 1 of 12026 (to date), Preclinical (animal, in vitro, computational): 3 of 42026 (to date), Reviews and meta-analyses: 1 of 4Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified01020304019942001200820152026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
199442006
19951330016
1996930012
19971864028
199815115031
19991582429
20008121021
20015114020
20025101117
2003271010
2004352010
200503306
200615006
200712003
200804116
200905005
201004004
201103104
201207007
201305005
201404105
201512104
201604004
201704004
201804105
201903003
202003003
202104015
202201001
202303003
202401001
202501001
2026 (to date)03104

Study types

Animal study118
Other clinical trial70
In vitro study34
Review29
Randomized controlled trial25
Not yet classified5
Observational human study4
Editorial, letter or other2
Case report1
Computational study1

Research areas

From MeSH major topics. A paper can be in several areas.

Endocrinology137
Cardiovascular65
Neurological and mental health55
Metabolic health40
Obesity and weight management27
Longevity and aging23
Musculoskeletal20
Reproductive and sexual health13
Gastrointestinal10
Oncology10
Immune system6
Tissue repair3

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.

    European journal of endocrinology · March 1, 2002 · Randomized controlled trial · cited 6 times

    PMID 11888836 · DOI 10.1530/eje.0.1460310 · Human clinical research

  2. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.

    The Journal of clinical endocrinology and metabolism · October 1, 2001 · Randomized controlled trial · cited 720 times · open access

    PMID 11600590 · DOI 10.1210/jcem.86.10.8098 · Human clinical research

  3. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

    The Journal of clinical endocrinology and metabolism · March 1, 2001 · Randomized controlled trial · cited 516 times

    PMID 11238504 · DOI 10.1210/jcem.86.3.7314 · Human clinical research

  4. Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans.

    Journal of endocrinological investigation · February 1, 2001 · Randomized controlled trial · cited 12 times

    PMID 11263473 · DOI 10.1007/bf03343815 · Human clinical research

  5. Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.

    Journal of internal medicine · June 1, 2000 · Randomized controlled trial · cited 26 times · open access

    PMID 10886488 · DOI 10.1046/j.1365-2796.2000.00676.x · Human clinical research

  6. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.

    The Journal of clinical endocrinology and metabolism · July 1, 1999 · Randomized controlled trial · cited 97 times

    PMID 10404825 · DOI 10.1210/jcem.84.7.5811 · Human clinical research

  7. Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans.

    Journal of endocrinological investigation · April 1, 1999 · Randomized controlled trial · cited 79 times · open access

    PMID 10342360 · DOI 10.1007/bf03343555 · Human clinical research

  8. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.

    Journal of endocrinological investigation · February 1, 1999 · Randomized controlled trial · cited 16 times

    PMID 10195374 · DOI 10.1007/bf03350886 · Human clinical research

  9. Growth hormone secretagogues: mechanism of action and use in aging.

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · February 1, 1998 · Randomized controlled trial · cited 19 times

    PMID 10990440 · DOI 10.1016/s1096-6374(98)80317-1 · Human clinical research

  10. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.

    Neuroendocrinology · December 1, 1997 · Randomized controlled trial · cited 43 times

    PMID 9430449 · DOI 10.1159/000127269 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

    Endocrine reviews · October 1, 1998 · Review · cited 837 times

    PMID 9793762 · DOI 10.1210/edrv.19.5.0346 · Reviews and meta-analyses

  2. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

    The Journal of cell biology · December 16, 2002 · Animal study · cited 724 times · open access

    PMID 12486113 · DOI 10.1083/jcb.200207165 · Animal studies

  3. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.

    The Journal of clinical endocrinology and metabolism · October 1, 2001 · Randomized controlled trial · cited 720 times · open access

    PMID 11600590 · DOI 10.1210/jcem.86.10.8098 · Human clinical research

  4. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

    The Journal of clinical endocrinology and metabolism · March 1, 2001 · Randomized controlled trial · cited 516 times

    PMID 11238504 · DOI 10.1210/jcem.86.3.7314 · Human clinical research

  5. Growth hormone secretagogue binding sites in peripheral human tissues.

    The Journal of clinical endocrinology and metabolism · October 1, 2000 · In vitro study · cited 416 times

    PMID 11061542 · DOI 10.1210/jcem.85.10.6846 · In vitro studies

Latest publications

  1. Histopathological and immunohistochemical characterization of MPTP-associated pancreatic injury and its attenuation by Hexarelin in mice.

    Journal of molecular histology · September 18, 2026 · Animal study · cited 0 times

    PMID 42758352 · DOI 10.1007/s10735-026-10976-z · Animal studies

  2. Protective and restorative effects of hexarelin on MPTP-induced lung injury in mice.

    Journal of basic and clinical physiology and pharmacology · August 21, 2026 · Animal study · cited 0 times

    PMID 42619489 · DOI 10.1515/jbcpp-2026-0178 · Animal studies

  3. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

    Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access

    PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses

  4. Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection.

    Indian journal of pharmacology · March 2, 2026 · Animal study · cited 0 times · open access

    PMID 41766237 · DOI 10.4103/ijp.ijp_176_24 · Animal studies

  5. Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry.

    Journal of analytical toxicology · July 1, 2025 · In vitro study · cited 1 times

    PMID 40465419 · DOI 10.1093/jat/bkaf038 · In vitro studies

  6. Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator.

    Frontiers in pharmacology · February 7, 2024 · Animal study · cited 3 times · open access

    PMID 38384295 · DOI 10.3389/fphar.2024.1303342 · Animal studies

  7. Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.

    Nanoscale · December 7, 2023 · Computational study · cited 20 times · open access

    PMID 37982184 · DOI 10.1039/d3nr05571j · Computational studies

  8. Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.

    European journal of medical research · September 14, 2023 · Animal study · cited 14 times · open access

    PMID 37710348 · DOI 10.1186/s40001-023-01318-w · Animal studies

  9. Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein.

    International journal of molecular sciences · January 4, 2023 · In vitro study · cited 4 times · open access

    PMID 36674509 · DOI 10.3390/ijms24020993 · In vitro studies

  10. Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models.

    Frontiers in physiology · January 21, 2022 · Animal study · cited 2 times · open access

    PMID 35126171 · DOI 10.3389/fphys.2021.766818 · Animal studies

Browse all 289 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Examorelin; Hexarelin

((TITLE_ABS:"Examorelin" OR CHEM:"Examorelin") OR (TITLE_ABS:"Hexarelin" OR CHEM:"Hexarelin")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Hexarelin (Examorelin) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/hexarelin